(Q40327142)

19 September 2017

Biphasic ⁶⁸Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma (English)

1 reference

19 September 2017

5

Philipp Ströbel

1 reference

19 September 2017

Carsten-Oliver Sahlmann

1

1 reference

19 September 2017

Birgit Meller

2

1 reference

19 September 2017

Caroline Bouter

3

1 reference

19 September 2017

Christian Oliver Ritter

4

1 reference

19 September 2017

Joachim Lotz

6

1 reference

19 September 2017

Lutz Trojan

7

1 reference

19 September 2017

Johannes Meller

8

1 reference

19 September 2017

Sameh Hijazi

9

1 reference

19 September 2017

12 November 2015

1 reference

19 September 2017

8

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

19 September 2017

43

1 reference

19 September 2017

5

1 reference

19 September 2017

898-905

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-015-3251-y

19 September 2017

0 references

cites work

International variation in prostate cancer incidence and mortality rates.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3251-Y

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3251-Y

Impact of dual-time-point (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3251-Y

Dual time point 2-[18F]fluoro-2'-deoxyglucose positron emission tomography in chronic bacterial osteomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3251-Y

Twins in spirit - episode I: comparative preclinical evaluation of [(68)Ga]DOTATATE and [(68)Ga]HA-DOTATATE

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3251-Y

A Novel Cytoplasmic Tail MXXXL Motif Mediates the Internalization of Prostate-specific Membrane Antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3251-Y

68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3251-Y

Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3251-Y

New prospects for PET in prostate cancer imaging: a physicist's viewpoint.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3251-Y

Impact of time-of-flight on PET tumor detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3251-Y

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3251-Y

68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3251-Y

PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3251-Y

Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3251-Y

Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3251-Y

The Long-Term Clinical Impact of Biochemical Recurrence of Prostate Cancer 5 or More Years After Radical Prostatectomy

21 January 2018

1 reference

12 December 2020

Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga-PSMA-positron emission tomography/computerized tomography.

1 reference

12 December 2020

Prostate specific membrane antigen- a target for imaging and therapy with radionuclides.

1 reference

12 December 2020

Cationic eluate pretreatment for automated synthesis of [⁶⁸Ga]CPCR4.2.

1 reference

12 December 2020

Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy

1 reference

12 December 2020

[(68)Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice

1 reference

12 December 2020

Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes

1 reference

12 December 2020

10.1007/S00259-015-3251-Y

Identifiers

DOI

1 reference

19 September 2017

1 reference